Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hagop Kantarjian

Showing results (1-10 of 1,199) with videos related to

Pageof 120
Sort By:
Journal of Oncology Practice|September 19, 2014
Chemotherapy drug shortages in the United States revisitedHagop Kantarjian
Journal of the National Comprehensive Cancer Network : JNCCN|November 11, 2005
Trends in the management of chronic myelogenous leukemiaHagop Kantarjian
Clinical Advances in Hematology & Oncology : H&O|February 6, 2009
Second generation tyrosine kinase inhibitors for the treatment of chronic myelogenous leukemia. [An interview with Hagop Katarjian by H&O]Hagop Kantarjian
Hematology (Amsterdam, Netherlands)|April 18, 2012
Monoclonal antibodies in adult acute lymphoblastic leukemiaHagop Kantarjian
American Journal of Hematology|November 25, 2015
Acute myeloid leukemia--major progress over four decades and glimpses into the futureHagop Kantarjian
Bone Marrow Transplantation|May 13, 2021
Emil J. Freireich: Legend in cancer research (March 16, 1927-February 1, 2021)Hagop Kantarjian
Journal of Oncology Practice|February 15, 2019
Poor Penetration of Existing Effective Chemoimmunotherapy for the Treatment of Older Patients With Newly Diagnosed Acute Lymphocytic Leukemia (ALL) or Refractory/Relapsed ALLHagop Kantarjian, Susan O'Brien
The Lancet. Oncology|February 19, 2017
Malignancy-associated haemophagocytic lymphohistiocytosis in adultsNaval Daver, Hagop Kantarjian
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
New targeted approaches in chronic myeloid leukemiaJorge Cortes, Hagop Kantarjian
Seminars in Hematology|February 13, 2007
Introduction: chronic myelogenous leukemia (CML)Elias Jabbour, Hagop Kantarjian
Pageof 120

Showing results (1-10 of 1,199) with videos related to

Sort By:
Pageof 120
Journal of Oncology Practice|September 19, 2014
Chemotherapy drug shortages in the United States revisitedHagop Kantarjian
Journal of the National Comprehensive Cancer Network : JNCCN|November 11, 2005
Trends in the management of chronic myelogenous leukemiaHagop Kantarjian
Clinical Advances in Hematology & Oncology : H&O|February 6, 2009
Second generation tyrosine kinase inhibitors for the treatment of chronic myelogenous leukemia. [An interview with Hagop Katarjian by H&O]Hagop Kantarjian
Hematology (Amsterdam, Netherlands)|April 18, 2012
Monoclonal antibodies in adult acute lymphoblastic leukemiaHagop Kantarjian
American Journal of Hematology|November 25, 2015
Acute myeloid leukemia--major progress over four decades and glimpses into the futureHagop Kantarjian
Bone Marrow Transplantation|May 13, 2021
Emil J. Freireich: Legend in cancer research (March 16, 1927-February 1, 2021)Hagop Kantarjian
Journal of Oncology Practice|February 15, 2019
Poor Penetration of Existing Effective Chemoimmunotherapy for the Treatment of Older Patients With Newly Diagnosed Acute Lymphocytic Leukemia (ALL) or Refractory/Relapsed ALLHagop Kantarjian, Susan O'Brien
The Lancet. Oncology|February 19, 2017
Malignancy-associated haemophagocytic lymphohistiocytosis in adultsNaval Daver, Hagop Kantarjian
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
New targeted approaches in chronic myeloid leukemiaJorge Cortes, Hagop Kantarjian
Seminars in Hematology|February 13, 2007
Introduction: chronic myelogenous leukemia (CML)Elias Jabbour, Hagop Kantarjian
Pageof 120